Eden Transfer Patients: Plans, Costs & Fit (2026)

Last reviewed: September 2, 2026 Last updated: September 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Eden is a reasonable transfer destination if you value a results-based money-back pledge and prefer simplicity over format choice. The program charges $198/month for semaglutide or $298/month for tirzepatide—each an all-in price covering medication ($99 or $199) plus a mandatory $99/month membership—and allows cancellation anytime. Eden offers injections only and operates on monthly terms exclusively; no multi-month prepaid plans exist. PlexusDx charges $189/month for semaglutide or $289/month for tirzepatide on comparable month-to-month terms, also with cancel-anytime flexibility, and provides lower committed-term rates for patients willing to prepay three or six months. PlexusDx adds injection, oral, and microdose formats but carries no money-back guarantee. The month-to-month cost difference is $9/month ($108/year) on both medications, with wider gaps if you commit to PlexusDx multi-month terms. Both programs ship compounded medications from licensed pharmacies, require provider approval, and include the consultation, prescription, and delivery in the listed price.

At-a-glance comparison: Eden vs PlexusDx for transfer patients

Prices verified July 19, 2026 (Eden) and July 17–23, 2026 (PlexusDx). All figures represent standard ongoing rates; PlexusDx multi-month figures are prepaid totals divided by term length (our calculation).

Month-to-month pricing: like-for-like comparison

Eden publishes two all-in monthly prices: $198 for semaglutide and $298 for tirzepatide. Each price comprises a medication charge ($99 for semaglutide, $199 for tirzepatide) plus a mandatory $99/month Eden Membership fee that recurs as a separate line item. The checkout page states "Card won't be charged until plan is medically approved within 24 hours," and completing the purchase means you agree to the monthly membership at $99/month. No multi-month plans or lower committed-term rates appear anywhere in Eden's offer; the program operates on rolling monthly terms only.

PlexusDx charges $189/month for semaglutide and $289/month for tirzepatide on month-to-month terms—one all-inclusive charge covering the online provider visit, prescription, medication, and shipping with no separate membership fee. The PlexusDx month-to-month plan also allows cancellation anytime. Over twelve months the cost difference is modest but consistent: Eden runs $2,376/year for semaglutide versus PlexusDx $2,268/year (a $108 annual difference), and $3,576/year for tirzepatide versus PlexusDx $3,468/year (also $108/year). Both calculations assume uninterrupted monthly billing and are our calculation from the verified per-month rates.

PlexusDx additionally offers lower committed-term rates for patients willing to prepay: semaglutide drops to $169/month on a three-month plan or $149/month on a six-month plan, and tirzepatide falls to $269/month (three-month) or $249/month (six-month). These prepaid options have no Eden equivalent—Eden's catalog contains only the monthly-only pricing—so a like-for-like comparison on multi-month terms is not possible. Transfer patients accustomed to monthly flexibility will find both programs accommodate that preference; those seeking to lock in a lower per-month cost by committing upfront will find that option exclusively at PlexusDx.

Billing structure and membership model

Eden's two-charge model may matter to transfer patients who prefer unified billing or who want to avoid tracking multiple recurring fees. Each Eden cycle generates a medication charge ($99 or $199) and a separate $99 membership charge; both recur monthly until canceled. The membership fee appears on the same checkout page as the advertised price, and completing the purchase commits you to the monthly membership; no version of Eden's compounded GLP-1 program exists without the membership component. PlexusDx consolidates everything—consultation, prescription, medication, and shipping—into a single monthly charge with no membership layer, which some patients find simpler for budgeting and others find irrelevant if the total cost is their only concern.

Both programs present their full monthly obligation transparently at checkout, and both allow cancellation anytime on the month-to-month plan, so neither program locks transfer patients into an extended contract. PlexusDx's three-month and six-month plans are prepaid in full and represent a term commitment, but the baseline month-to-month option at both Eden and PlexusDx carries identical cancel-anytime flexibility.

Money-back pledge vs. no guarantee

Eden offers a headline pledge: "Lose 10% in 6 months or get your money back" on compounded plans. The evidence captured contains only the headline; full conditions—whether the guarantee covers membership fees, medication costs, or both, and what documentation or compliance milestones the refund requires—were not present in the source material. Transfer patients considering Eden on the strength of this pledge should confirm the complete terms at checkout or with Eden support before purchasing. No comparable money-back guarantee appears in PlexusDx's offer; the program prices its service lower on a month-to-month basis and lower still on prepaid terms, but it provides no refund mechanism tied to weight-loss outcomes.

For patients who derive confidence from a results-based safety net, Eden's pledge may justify the $9/month premium on month-to-month terms. For patients who view such guarantees as marketing rather than material protection—or who prioritize format flexibility and locked-in pricing—PlexusDx's structure may prove more decision-useful.

Medication formats and route flexibility

Eden provides injections exclusively; the program catalog contains no oral capsule or microdose alternative. PlexusDx operates five weight-management protocols: semaglutide injection, tirzepatide injection, semaglutide oral capsules, tirzepatide oral capsules, and a microdose GLP-1 injection designed for maintenance or side-effect mitigation. Transfer patients who tolerate injections well and plan to continue that route will find either program technically sufficient. Those exploring oral delivery—to avoid needles, simplify travel, or test absorption differences—or those interested in stepping down to a microdose for long-term maintenance will find those options only at PlexusDx.

The microdose protocol runs $129/month, a meaningful cost reduction for patients who have reached goal weight and want to sustain results without the expense of full-dose therapy. Eden's injection-only, monthly-only model offers no equivalent step-down or format-switching path within the same program, so patients who anticipate needing route flexibility during the transfer period may weigh that gap heavily.

Pharmacy support and optional genetics

PlexusDx includes a free Doctor of Pharmacy check-in as part of every weight-management protocol; patients can discuss dosing, side effects, drug interactions, and administration technique with a licensed pharmacist at no additional charge. Eden's evidence does not mention pharmacy support, which does not prove its absence but does mean we cannot compare the two programs on that dimension with confidence. Similarly, PlexusDx offers an optional DNA test ($298 standalone, or $99 for active patients) that examines how genetic variants may influence medication metabolism, though the test does not select or predict which medication a provider will prescribe—clinical judgment remains the determining factor. Eden's materials contain no reference to genetics add-ons.

Transfer patients who value pharmacist access or who are curious about genetic insights will find documented support for both at PlexusDx. Those features may hold no decision weight for patients focused purely on medication cost and results guarantee, but they represent included or available services that differentiate the two programs on non-price axes.

Choose Eden if…

• You want a money-back pledge tied to a six-month weight-loss target and are willing to pay $9/month more (month-to-month) for that assurance.
• You tolerate injections well, plan to continue injection therapy indefinitely, and see no need for oral or microdose alternatives.
• You prefer month-to-month flexibility and have no interest in prepaying to capture a lower per-month rate.
• You are comfortable with a two-charge billing model (medication plus membership) and view the membership fee as an acceptable part of the package.

Choose PlexusDx if…

• You want the lowest available month-to-month cost on semaglutide or tirzepatide injections, or you are willing to prepay three or six months to lock in per-month rates below any Eden option.
• You value route flexibility—oral capsules to avoid injections, or microdose therapy for long-term maintenance—within a single program.
• You prefer one all-inclusive monthly charge with no separate membership fee to track.
• You want included pharmacist support and optional genetic testing as part of a broader clinical toolkit, even if those features do not directly lower the medication cost.
• You do not require a money-back weight-loss guarantee and instead prioritize transparent per-month pricing and format choice.

What this comparison cannot tell you

The evidence does not document Eden's prescriber credentials, average time-to-approval, refill logistics, patient-support responsiveness, or the full terms of its money-back pledge. It also does not reveal whether Eden adjusts pricing by dose tier, though the published rates state they cover the medication at any dose. For PlexusDx the same-price-at-every-dose policy is documented, but we do not know whether Eden operates identically or charges more as patients titrate upward. Transfer patients should confirm dose-pricing policy, membership cancellation mechanics, and guarantee conditions directly with Eden before finalizing a switch. Similarly, while both programs state they work with licensed compounding pharmacies, neither source specifies 503A versus outsourcing-facility designation for Eden; PlexusDx is documented as working exclusively with 503A facilities.

Neither program's patient-satisfaction scores, prior-authorization processes, or average response times appear in the evidence, so this comparison cannot assess operational quality or customer-experience differences. Cost and contract terms are transparent; service delivery remains outside the scope of the verified data.

Methodology and freshness

All Eden pricing was captured from the provider's public checkout flow on July 19, 2026. PlexusDx pricing was captured from verified internal and public sources between July 17 and July 23, 2026. All figures represent standard ongoing rates and prepaid totals verified at the dates shown. The twelve-month cost projections multiply the verified per-month rate by twelve and are our calculation. PlexusDx three-month and six-month per-month figures are prepaid totals divided by the term length and are our calculation. Where a feature is listed as "not mentioned in evidence," that absence reflects the limits of the captured material, not a confirmed absence of the feature in the program itself. This comparison was published September 2, 2026, and will be updated when new evidence becomes available or when either program changes its pricing, terms, or catalog.

Frequently Asked Questions

Does Eden's $198 semaglutide price include the provider visit and shipping?

Yes. The $198/month all-in price for semaglutide comprises a $99 medication charge and a $99/month mandatory membership; both the consultation and shipping are included, and your card is not charged until a provider approves your plan within 24 hours.

Can I cancel Eden or PlexusDx if I want to switch back to my original provider?

Yes. Both Eden and PlexusDx allow cancellation anytime on month-to-month plans. Eden operates monthly terms only; PlexusDx also offers three-month and six-month prepaid plans that represent a term commitment, but the baseline month-to-month option at both programs carries cancel-anytime flexibility.

What does Eden's "lose 10% in 6 months or get your money back" pledge actually cover?

The evidence captures only the headline pledge; full terms—whether the refund includes membership fees, medication costs, or both, and what compliance or documentation the guarantee requires—were not present in the source material. Confirm the complete conditions with Eden before purchasing if the guarantee is a deciding factor.

Does PlexusDx charge more when I move to a higher dose of semaglutide or tirzepatide?

No. PlexusDx pricing is the same at every dose; the published per-month rate covers medication at any prescribed strength, so titrating upward does not trigger a price increase. Eden's policy on dose-based pricing is not documented in the evidence, so transfer patients should confirm whether the $198 semaglutide or $298 tirzepatide rate holds across all dose tiers.

If I want to switch from injections to oral capsules mid-treatment, can I do that at Eden or PlexusDx?

PlexusDx offers semaglutide and tirzepatide in both injection and oral-capsule formats, so switching routes within the same program is possible subject to provider approval. Eden provides injections only, so moving to an oral format would require leaving Eden and transferring to a provider that offers capsules.

Sources

• Eden pricing and terms, captured from public checkout flow, July 19, 2026.
• PlexusDx pricing, billing structure, cancellation policy, and catalog, verified from internal and public sources, July 17–23, 2026.
• PlexusDx pharmacy support and genetics add-on, verified July 17–23, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.